BCFS001099-Tufts-Babinski-MultipleSclerosis [Landing Page]

Apply Now Multiple Sclerosis Research Study Researchers at Tufts Medical Center are evaluating the efficacy, safety, and tolerability of remibrutinib, to support regulatory approval worldwide as a treatment for RMS. Apply Now Fast Facts Ages 18-55 Diagnosed with RRMS OR SPMS Cost for Transportation and Expenses Covered Conducted in Boston, MA Study Background Researchers at […]